COVID-19: Why vaccinating those aged 18-44 is an uphill task for Bihar
The state has less than 1% of the required number of vaccine doses
Delta variant of COVID-19 can infect vaccinated people finds AIIMS study
Coronavirus update: Covaxin works against ‘double mutant’, claims ICMR
Covishield to cost Rs 600 a jab at private hospitals
Tika Utsav and Vaccine Maitri: Finding the right balance
67% medicines produced in India are exported to developing countries
Free COVID-19 vaccines in India from June 21: Everything you need to know
The Centre will buy 75% of total vaccine production and give it to states free of cost
Covid-19 vaccination drive rolled out in Punjab and Himachal Pradesh, skepticism lingers
Some ASHA workers refused to get the jab on Saturday
Covishield, Covaxin may work against ‘double mutant’
ICMR, CCMB assurance can be a boon amid rising prevalence of B.1.617
COVID-19 vaccine: After doses, states struggle to get syringes
Manufacturers foresaw demand boom, asked Centre to draw up plan in 2020 itself
COVID-19: Expert committee approves Covaxin for children aged 2-18 years
No data on clinical trials of Bharat Biotech vaccine on children available publicly yet
Norway deaths, social media rumours: Why healthcare workers in Bihar are staying away from vaccines
Nearly 40% healthcare workers scheduled for first 3 days give the jab a miss
Growing COVID-19 infection among children a concern in Odisha: Sources
Of the total cases registered between March 1 and May 16, 8% were among those under 18
Is WHO nod for China’s Sinovac a domino effect of COVID-19 second wave in India?
The process of approval has become slower since Pfizer and BioNTech received approval
Odisha makes negative RT-PCR report must for entry into state
Hospitals urged to treat only emergency cases
As told to Parliament (December 7, 2021): Thousands of posts vacant at India’s rural health centres
All that was discussed in the House through the day
Millions of doses set to expire by September as India’s COVID-19 vaccination drive stagnates
Share of population completely vaccinated grew just 5 percentage points since April
ICMR, central drug regulator admit COVID-19 vaccine side effects; health ministry rubbishes claim
Government called revelations ‘ill-informed & erroneous’
Vaccine Scarcity: Government projection of vaccine demand goes haywire
Not expecting second surge, Centre exported more than 60 million doses
Bharat Biotech’s vaccine, Covaxin not as effective as Serum Institutes of India’s Covishield
Study led by National Centre for Biological Sciences intended to shape future vaccine strategies by offering insights into the immunity acquired …
WATCH: How Serum Institute of India is pricing Covishield
Vaccination against COVID-19 will undergo major modifications next month. Here’s a quick glance.
Covaxin has not got emergency use approval from WHO since 6 months. Know the process here
The approval is stuck in the final fifth stage of the process when clinical data on safety, efficacy, quality and risk management plan are evaluated
COVID-19: India trips on its patent waiver proposal
New Delhi has not backed its WTO proposal to suspend intellectual property rights on COVID-19 pharma products with robust action
Confronting head-on the vexed pricing of COVID -19 vaccines
It would cost anything between Rs 13,821 crore to Rs 1,10,568 crore to vaccinate the 20-44 age population
What are India’s options for a booster dose of COVID-19 vaccine
Hyderabad-based Biological E’s Corbevax and SII’s Covovax, both of which are protein-based vaccines, are India’s best bet for a …
WHO finally gives emergency use nod for Covaxin
Those administered indigenous Indian vaccine against COVID-19 can now travel abroad unhindred
Lateral thoughts: COVID-19 vaccines and a game of chance
Would you be compensated for adverse reactions to the COVID-19 vaccines?